Advertisement

Organisation › Details
Nuclera Ltd.
Nuclera’s mission is to better human health by enabling scientists to easily access the proteins they need for drug discovery research. The Company’s eProtein Discovery™ benchtop system accelerates protein expression and purification workflows within research labs. The platform reduces the timelines and costs associated with protein expression and purification through automated construct screening to inform protein scale-up resulting in mg amounts in less than 48 hours. Integrating digital microfluidics, protein quality assays, and cell-free protein synthesis on smart cartridges, eProtein Discovery enables rapid access to even challenging proteins at high quality. Founded in 2013, Nuclera’s offices are located in Cambridge (UK) and Boston (US). *
![]() |
Start | 2023-04-13 renamed |
Group | Nuclera (Group) | |
Predecessor | Nuclera Nucleics Ltd. | |
![]() |
Industry | BIOTECH |
Industry 2 | bioprinter (bioprinting system) | |
![]() |
Person | Chen, Michael C. (Nuclera 202202 CEO + Co-Founder) |
![]() |
Region | Cambridge, Cambridgeshire |
Country | United Kingdom (GB) | |
Street | Station Road One Vision Park | |
City | CB24 9NP Impington, Cambridge | |
Address record changed: 2024-04-01 | ||
Basic data | Employees | D: 101 to 500 (2023-09-14) |
* Document for »About Section«: Nuclera Ltd.. (3/14/24). "Press Release: Nuclera Appoints Joseph Bertelsen as Chief Commercial Officer". Cambridge. | ||
Record changed: 2024-04-07 |
Advertisement

More documents for Nuclera (Group)
- [1] Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing > Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA....
- [2] Nuclera Ltd.. (3/14/24). "Press Release: Nuclera Appoints Joseph Bertelsen as Chief Commercial Officer". Cambridge....
- [3] Nuclera Ltd.. (2/7/24). "Press Release: Nuclera Partners with Sharp Life Science Advancing Its Digital Microfluidics Capability"....
- [4] Nuclera Nucleics Ltd.. (2/2/22). "Press Release: Nuclera Raises $42.5M in First Close of Series B for Desktop Protein Printer". Cambridge....
- [5] Nuclera Nucleics Ltd.. (1/18/22). "Press Release: Nuclera Announces Expansion with New US Subsidiary". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top